INGN
$6.10-0.06 (-0.97%)
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen thera...
Recent News
Inogen CEO: Turnaround Driving Positive EBITDA, $3B TAM Expansion Beyond Portable Oxygen
Inogen (NASDAQ:INGN) CEO Kevin Smith told investors at the KeyBanc Conference that the company has spent the past two years stabilizing operations and repositioning for profitable growth, while expanding beyond its historical reliance on portable oxygen concentrators (POCs). The discussion was held
Inogen Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y
INGN posts narrower Q4 loss and 2% revenue rise, but shares dip as U.S. sales and rentals weaken despite international strength.
Inogen, Inc. Q4 2025 Earnings Call Summary
Moby summary of Inogen, Inc.'s Q4 2025 earnings call
Inogen Q4 Earnings Call Highlights
Inogen (NASDAQ:INGN) executives highlighted improving profitability, international momentum, and a broadened product portfolio during the company’s fourth-quarter 2025 earnings call held February 24, 2026. Management also introduced 2026 revenue guidance and disclosed a new $30 million share repurch
Inogen Inc (INGN) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Initiatives ...
Inogen Inc (INGN) reports a 4% annual revenue increase and unveils a $30 million share repurchase program, signaling confidence in its growth strategy.